GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Enterprise Value

Shenzhen Kangtai Biological Products Co (SZSE:300601) Enterprise Value : ¥21,740 Mil (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shenzhen Kangtai Biological Products Co's Enterprise Value is ¥21,740 Mil. Shenzhen Kangtai Biological Products Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥883 Mil. Therefore, Shenzhen Kangtai Biological Products Co's EV-to-EBIT ratio for today is 24.63.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Shenzhen Kangtai Biological Products Co's Enterprise Value is ¥21,740 Mil. Shenzhen Kangtai Biological Products Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥883 Mil. Therefore, Shenzhen Kangtai Biological Products Co's EV-to-EBITDA ratio for today is 24.63.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Shenzhen Kangtai Biological Products Co's Enterprise Value is ¥21,740 Mil. Shenzhen Kangtai Biological Products Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,181 Mil. Therefore, Shenzhen Kangtai Biological Products Co's EV-to-Revenue ratio for today is 6.83.


Shenzhen Kangtai Biological Products Co Enterprise Value Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Enterprise Value Chart

Shenzhen Kangtai Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56,394.60 116,572.21 66,894.81 36,159.96 31,493.36

Shenzhen Kangtai Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36,717.55 29,950.26 34,059.53 31,493.36 26,084.86

Competitive Comparison of Shenzhen Kangtai Biological Products Co's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Kangtai Biological Products Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Kangtai Biological Products Co's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Kangtai Biological Products Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Shenzhen Kangtai Biological Products Co's Enterprise Value falls into.



Shenzhen Kangtai Biological Products Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Shenzhen Kangtai Biological Products Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Shenzhen Kangtai Biological Products Co's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Kangtai Biological Products Co  (SZSE:300601) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Shenzhen Kangtai Biological Products Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=21740.018/882.669
=24.63

Shenzhen Kangtai Biological Products Co's current Enterprise Value is ¥21,740 Mil.
Shenzhen Kangtai Biological Products Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥883 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Shenzhen Kangtai Biological Products Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=21740.018/882.669
=24.63

Shenzhen Kangtai Biological Products Co's current Enterprise Value is ¥21,740 Mil.
Shenzhen Kangtai Biological Products Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥883 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Shenzhen Kangtai Biological Products Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=21740.018/3180.715
=6.83

Shenzhen Kangtai Biological Products Co's current Enterprise Value is ¥21,740 Mil.
Shenzhen Kangtai Biological Products Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,181 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Kangtai Biological Products Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Executives
Liu Jian Kai Directors, executives
Tao Jin Secretary Dong
Zheng Hai Fa Directors, executives
Zhou Hui Executives
Miao Xiang Directors, executives
Wen Fei Dong Director
Du Wei Min Directors, executives
Lv Zhi Yun Supervisors
Gan Jian Hui Executives
Zhu Zheng Yu Executives
Liu Qun Executives
Li Tong Executives
Yuan Li Ping Director
Li Xiang Ming Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines